rivastigmine tartrate 1.5 mg
1 INDICATIONSAND USAGE Rivastigmine tartrate is an acetylcholinesterase inhibitor indicated for treatment of: • Mild-to-moderate dementia of the Alzheimer's type (AD) ( 1.1 ) • Mild-to-moderate dementia associated with Parkinson's disease (PD) ( 1.2 ) 1.1 Alzheimer's Disease Rivastigmine tartrate capsules, USP are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). 1.2 Parkinson's Disease Dementia Rivastigmine tartrate capsules, USP are indicated for the treatment of mild-to-moderate dementia associated with Parkinson's disease (PD).
Cadila Pharmaceuticals Limited
CAPSULE YELLOW C 91
Related Pills
rivastigmine tartrate 6 mg
Cadila Pharmaceuticals Limited
rivastigmine tartrate 4.5 mg
Cadila Pharmaceuticals Limited
rivastigmine tartrate 3 mg
Cadila Pharmaceuticals Limited
lamotrigine 250 mg
remedyrepack inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
RIVASTIGMINE TARTRATE capsules
RIVASTIGMINE TARTRATE capsules, USP equivalent to 1.5 mg, 3 mg, 4.5 mg, or 6 mg of rivastigmine base are available as follows: 1.5 mg capsule - white to off white powder filled in size "2" hard gelatin capsules with yellow opaque color cap and yellow opaque color body imprinted "C 91". Bottles of 60 NDC 71209-012-03 Bottles of 500 NDC 71209-012-10 3 mg capsule - white to off white powder filled in size "2" hard gelatin capsules with orange opaque color cap and orange opaque color body imprinted "C 92". Bottles of 60 NDC 71209-013-03 Bottles of 500 NDC 71209-013-10 4.5 mg capsule - white to off white powder filled in size "2" hard gelatin capsules with red opaque color cap and red opaque color body imprinted "C 93". Bottles of 60 NDC 71209-014-03 Bottles of 500 NDC 71209-014-10 6 mg capsule - white to off white powder filled in size "2" hard gelatin capsules with red opaque color cap and orange opaque color body imprinted "C 94". Bottles of 60 NDC 71209-015-03 Bottles of 500 NDC 71209-015-10 Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store in a tight container.
More pills like CAPSULE C 91